NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Systematic Review and Meta-Analysis of Multaq® for Safety in Atrial Fibrillation

CompletedN/A

Sponsor: Sanofi

Conditions: Atrial Fibrillation

Interventions: dronedarone, sotalol

Countries: France

A systematic literature review (SLR) will be conducted to understand the landscape of evidence on the relative safety and effectiveness/efficacy of dronedarone compared to sotalol in patients with AFib within interventional clinical trials and observational studies.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

Following eligibility criteria are defined to select relevant studies from the literature

* Adults with Atrial Fibrillation(AFib) (non-permanent, including paroxysmal or persistent, long-standing persistent AFib \[over 12 months\]))
* Participants have received either Dronedarone or Sotalol
* controlled clinical trials or comparative observational studies( prospective/retrospective cohort, case-control studies, population-based studies or registry based studies

Exclusion Criteria:

Exclusion criteria for potential participants are:

* Children/adolescents
* Permanent atrial fibrillation (AFib)

Locations (1)

Chilly-Mazarin, France